IGC Pharma, Inc. (IGC)
0.3019
0.00 (0.00%)
USD |
NYAM |
Apr 10, 16:00
0.30
0.00 (0.00%)
After-Hours: 20:00
IGC Pharma Total Liabilities (Quarterly) : 2.289M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| electroCore, Inc. | 21.27M |
| Lantern Pharma, Inc. | 4.505M |
| 4D Molecular Therapeutics, Inc. | 61.05M |
| NRX Pharmaceuticals, Inc. | 28.89M |
| Acurx Pharmaceuticals, Inc. | 2.421M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.712M |
| Shareholders Equity (Quarterly) | 7.423M |
| Debt to Equity Ratio | 0.0191 |
| Current Ratio | 0.8302 |
| Net Debt Paydown Yield | 0.12% |